Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07360210

Muscle Damage of the TFL (Tensor Fascia Latae) During Total Hip Arthroplasty (THA) Through Direct Anterior Approach (DAA)

Direct Anterior Approach (DAA) is known to cause damage to the TFL during the surgical approach, the point of this study is to evaluate the impact between the severity of the per operative TFL damage and the functional short term results.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Bordeaux, Bordeaux, France

Loading trial locations.

About this study

Total hip arthroplasty is one of the most frequent surgical procedure and it has changed the approach of hip arthrosis. There are a few surgical approaches frequently used : posterolateral approach, anterolateral approach and the direct anterior approach. It has been previously shown that the DAA is causing less muscle damage than the other surgical approaches, the anterior interval is considered as internervous and intermuscular muscle-sparing technique. However, several reports have proved that the DAA was also associated with muscle damage, particularly to the tensor fascia lata during the exposition with the instruments.

The purpose of this study is to determinate the correlation between the severity of muscle damage during surgery and the functional post operative short and medium term results. We underwent grading visible muscle damage during surgery after implant positioning by a grading system in 5 stages from 0 (intact or a few fibers) to 4 (more than 75% of muscle damage). Functional results were established by Harris Hip Score at 6 weeks and 6 months follow up.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult (>18 years old),
  • patient undergoing primary Total Hip Arthroplasty through Direct Anterior Approach for osteoarthritis

Exclusion criteria

  • hip dysplasia
  • leg length discrepancy greater than 2cm
  • history of homolateral hip surgery
  • neuromuscular pathology
  • patients declining the protocol

Treatment and study plan

Data collection and self-administered questionnaire

Other

Data collection and self-administered questionnaire (HHS and SF-36)

Primary outcomes

  1. Correlation between post operative functional results and TFL muscle damage

    Time frame: week 6

    Correlation between :

    • short term post operative functional results, evaluated by Harris Hip score at 6 weeks. Harris Hip score has 10 items with several propositions per each item and total score from 2 to 100 , and
    • TFL muscle damage grade during surgery evaluated with ATHLAS classification : score 0 (intact or few fibres), 1 (0-25% of fibres), 2 (25-50%), 3 (50-75%) et 4 (>75%)

Secondary outcomes

  1. Harris Hip score 6 months

    Time frame: 6 months

    Result of Harris Hip score at 6 months Harris Hip score has 10 items with several propositions per each item and total score from 2 to 100 ,

  2. Quality of life scale

    Time frame: 6 weeks, 6 months

    Evolution of SF-36 questionnaire score between 6 weeks and 6 months after total hip arthroplasty

Study contacts

Contact information is provided by the study sponsor or research team.

Arthur SEGUINEAU, MD

CONTACT

[email protected]

Julie BELLARD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Registry information

Official study title

Muscle Damage of the TFL (Tensor Fascia Latae) During Total Hip Arthroplasty (THA) Through Direct Anterior Approach (DAA), Evaluation of the Correlation With Short Term Functional Results

Acronym: TFL

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 22, 2026
Registry last updated
Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.